Product NDC: | 10544-210 |
Proprietary Name: | Hydroxyzine |
Non Proprietary Name: | Hydroxyzine |
Active Ingredient(s): | 25 mg/1 & nbsp; Hydroxyzine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10544-210 |
Labeler Name: | Blenheim Pharmacal, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088618 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100517 |
Package NDC: | 10544-210-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (10544-210-30) |
NDC Code | 10544-210-30 |
Proprietary Name | Hydroxyzine |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (10544-210-30) |
Product NDC | 10544-210 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydroxyzine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100517 |
Marketing Category Name | ANDA |
Labeler Name | Blenheim Pharmacal, Inc. |
Substance Name | HYDROXYZINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antihistamine [EPC],Histamine Receptor Antagonists [MoA] |